Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | AMGN | BMY | VRTX | GILD |
| Company | Halozyme Therapeutic | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 44.57 | 281.10 | 58.60 | 448.46 | 88.11 |
| High | 46.20 | 288.48 | 58.83 | 451.76 | 89.08 |
| Low | 44.10 | 278.56 | 57.67 | 445.38 | 87.77 |
| Last | 45.76 | 287.87 | 57.88 | 451.23 | 88.63 |
| Change | +0.95 | +7.92 | -0.35 | +3.22 | +0.88 |
| % Change | +2.12% | +2.83% | -0.60% | +0.72% | +1.00% |
| Volume | 1,875,500 | 4,759,300 | 11,239,601 | 1,651,100 | 4,781,700 |
| 20-Day Average Volume | 2,097,875 | 2,811,540 | 12,381,460 | 1,304,100 | 7,685,460 |
| Previous Close | 44.81 | 279.95 | 58.23 | 448.01 | 87.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 53.42 | 308.71 | 55.66 | 480.31 | 90.84 |
| 20-Day Raw Stochastic | 18.64% | 23.36% | 65.48% | 7.85% | 19.89% |
| 20-Day Relative Strength | 37.42% | 34.86% | 59.92% | 41.12% | 51.04% |
| Weighted Alpha | +13.78 | +0.94 | +25.01 | +18.38 | +23.88 |
| Today's Opinion | 40% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 40% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 8% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -21.92% since 11/13/24 | -4.50% since 11/13/24 | -0.91% since 11/13/24 | -8.77% since 11/13/24 | -4.32% since 11/13/24 |
| Low | 42.01 on 11/18/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.38 on 11/20/24 | 86.08 on 11/19/24 |
| High | 59.80 on 11/14/24 | 298.48 on 11/14/24 | 59.73 on 11/14/24 | 496.33 on 11/14/24 | 92.66 on 11/14/24 |
| 1-Month | |||||
| %Chg | -13.02% since 10/18/24 | -10.50% since 10/18/24 | +8.76% since 10/18/24 | -6.58% since 10/18/24 | +2.20% since 10/18/24 |
| Low | 42.01 on 11/18/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.38 on 11/20/24 | 85.60 on 10/22/24 |
| High | 62.13 on 11/11/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -24.90% since 08/20/24 | -12.38% since 08/20/24 | +18.17% since 08/20/24 | -7.42% since 08/20/24 | +18.57% since 08/20/24 |
| Low | 42.01 on 11/18/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.38 on 11/20/24 | 74.80 on 08/21/24 |
| High | 65.53 on 08/29/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +1.76% since 05/20/24 | -8.48% since 05/20/24 | +33.49% since 05/20/24 | +1.20% since 05/20/24 | +30.53% since 05/20/24 |
| Low | 42.01 on 11/18/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 65.53 on 08/29/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,701,042 | 150,482,384 | 118,100,752 | 115,375,568 | 109,359,840 |
| Shares Outstanding, K | 127,227 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 829,250,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 281,590,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 290,080,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 137,010,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.29 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.27 on 10/31/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/31/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 12.23 | 14.50 | 48.55 | 0.00 | 19.97 |